Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 4336 participants.

Also called NCT07442071

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 4,336 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07442071
  • EU CT 2023-505349-26-00
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07442071. Randomized; quadruple masking; primary purpose treatment. Start 2026-06 (anticipated); primary completion 2030-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome
Acronym
Low-EPI
Condition
Out-of-hospital Cardiac Arrest (OHCA)
Intervention (Drug)
Epinephrine 0.5 mg intravenous bolus
Intervention (Drug)
Epinephrine 1 mg intravenous bolus
Lead sponsor
Central Hospital, Nancy, France (class: other)

Record details

Record id
cardio:ct-nct07442071
Content hash
85d05ccd832a7aacbcd8334617ed28c741461f12c4c969edabbedf31c841813b